8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.95%
Revenue growth at 50-75% of 9843.T's 11.01%. Martin Whitman would worry about competitiveness or product relevance.
9.53%
Gross profit growth at 75-90% of 9843.T's 11.82%. Bill Ackman would demand operational improvements to match competitor gains.
43.67%
EBIT growth 75-90% of 9843.T's 49.02%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
30.10%
Operating income growth at 50-75% of 9843.T's 48.83%. Martin Whitman would doubt the firm’s ability to compete efficiently.
42.72%
Net income growth comparable to 9843.T's 42.17%. Walter Schloss might see both following similar market or cost trajectories.
42.72%
EPS growth similar to 9843.T's 42.17%. Walter Schloss would assume both have parallel share structures and profit trends.
42.72%
Similar diluted EPS growth to 9843.T's 40.97%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.00%
Share reduction while 9843.T is at 0.10%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 9843.T is at 0.85%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.78%
10Y revenue/share CAGR under 50% of 9843.T's 84.63%. Michael Burry would suspect a lasting competitive disadvantage.
-7.65%
Negative 5Y CAGR while 9843.T stands at 59.71%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
35.01%
3Y revenue/share CAGR similar to 9843.T's 34.24%. Walter Schloss would assume both companies experience comparable short-term cycles.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.39%
Net income/share CAGR at 50-75% of 9843.T's 97.89%. Martin Whitman might question if the firm’s product or cost base lags behind.
2.81%
Below 50% of 9843.T's 113.87%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
47.84%
3Y net income/share CAGR 50-75% of 9843.T's 68.38%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
28.23%
Below 50% of 9843.T's 121.80%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.77%
3Y equity/share CAGR 1.25-1.5x 9843.T's 54.11%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.16%
Firm’s AR is declining while 9843.T shows 29.90%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.48%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.44%
Asset growth well under 50% of 9843.T's 4.46%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.18%
BV/share growth above 1.5x 9843.T's 3.06%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-25.72%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
101.71%
SG&A growth well above 9843.T's 21.39%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.